Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing: Results for 68,308 subjects

Scandinavian Journal of Gastroenterology

Volumn 29, Issue 5, 1994, Pages 468-473

  Kewenter, J ^a   Brevinge, H ^a   Engaras B ^a   Haglind, E ^a   Ahren C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal neoplasm; Fecal occult blood testing; Follow up; Screening

Indexed keywords

ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OCCULT BLOOD; OCCULT BLOOD TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; SWEDEN;

ADENOMA; CARCINOMA; COLORECTAL NEOPLASMS; FALSE NEGATIVE REACTIONS; FECES; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OCCULT BLOOD; PROSPECTIVE STUDIES;

EID: 0028329546     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529409096840     Document Type: Article

References (21)

1. The Cancer Registry of Norway
2. Improved survival of patients with cancers of the colon and rectum
3. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects
4. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects
5. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomised study at Funen, Denmark
6. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study
7. Reducing mortality from colorectal cancer by screening for fecal occult blood
8. Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial
9. Rett syndrome related to fragile X (P22) in caffeine-induced lymphocyte culture
10. Role of dietary restriction in Haemoccult screening for colorectal cancer
11. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests
12. Value of retesting subjects with a positive Hemoccult in screening for colorectal cancer
13. Screening for colorectal carcinomas: an analysis of the sensitivity of Haemoccult
14. Rehydration of guaiac-based faecal occult blood tests in mass screening for colorectal cancer
15. Double contrast barium enema and flexible rectosigmoidoscopy: a reliable diagnostic combination for detection of colorectal neoplasm
16. Colon cancer control study: status and current issues
17. Interval cancers in screening with fecal occult blood test for colorectal cancer
18. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial